Applied Therapeutics Inc (APLT) last year’s performance of -74.22% is a clear signal for an entertaining trading season.

On Monday, Applied Therapeutics Inc (NASDAQ: APLT) opened higher 1.75% from the last session, before settling in for the closing price of $0.68. Price fluctuations for APLT have ranged from $0.65 to $10.62 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Company’s average yearly earnings per share was noted 1.41% at the time writing. With a float of $86.61 million, this company’s outstanding shares have now reached $116.36 million.

Let’s determine the extent of company efficiency that accounts for 25 employees. In terms of profitability, gross margin is 378.67%, operating margin of 43736.49%, and the pretax margin is 88772.51%.

Applied Therapeutics Inc (APLT) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Applied Therapeutics Inc is 25.56%, while institutional ownership is 88.04%. The most recent insider transaction that took place on Aug 22 ’24, was worth 78,880. In this transaction Chief Financial Officer of this company sold 13,530 shares at a rate of $5.83, taking the stock ownership to the 277,911 shares. Before that another transaction happened on Aug 22 ’24, when Company’s Chief Medical Officer sold 22,681 for $5.83, making the entire transaction worth $132,230. This insider now owns 986,853 shares in total.

Applied Therapeutics Inc (APLT) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 1.41% per share during the next fiscal year.

Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators

Check out the current performance indicators for Applied Therapeutics Inc (APLT). In the past quarter, the stock posted a quick ratio of 1.06.

Technical Analysis of Applied Therapeutics Inc (APLT)

Looking closely at Applied Therapeutics Inc (NASDAQ: APLT), its last 5-days average volume was 10.37 million, which is a jump from its year-to-date volume of 8.67 million. As of the previous 9 days, the stock’s Stochastic %D was 15.23%. Additionally, its Average True Range was 0.25.

During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 0.89%, which indicates a significant decrease from 23.01% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 94.97% in the past 14 days, which was lower than the 255.04% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $4.5548, while its 200-day Moving Average is $5.4786. However, in the short run, Applied Therapeutics Inc’s stock first resistance to watch stands at $0.7240. Second resistance stands at $0.7570. The third major resistance level sits at $0.8182. If the price goes on to break the first support level at $0.6298, it is likely to go to the next support level at $0.5686. Now, if the price goes above the second support level, the third support stands at $0.5356.

Applied Therapeutics Inc (NASDAQ: APLT) Key Stats

There are currently 116,356K shares outstanding in the company with a market cap of 80.40 million. Presently, the company’s annual sales total 9,990 K according to its annual income of -119,760 K. Last quarter, the company’s sales amounted to 120 K and its income totaled -68,590 K.